Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06348134
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-03-29
Brief Title:
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2 Breast Cancer Before and After Surgery
Sponsor:
University of Chicago
Organization:
University of Chicago
Organization Data
Organization:
University of Chicago
Class:
OTHER
Study ID:
IRB23-0502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Chicago
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None